Danone has invested €12 million in a new plant-based food production line at its Parets del Vallès factory dedicated exclusively to the manufacture of coconut and oat-based products under the company’s Activia, Alpro, and Oikos brands for both local and international markets.
As a result, Parets del Vallès will become Danone’s first hybrid factory that produces both dairy yogurts and plant-based alternatives.
Danone has committed to reinvest and become a “local-first company”, as it strengthens its plant-based business and offers more alternatives.
The company recently agreed to acquire Earth Island, maker of the dairy-free Follow Your Heart range.
Paolo Tafuri, CEO of Danone Spain, said they would drive the food revolution with innovation as the main force of transformation.
He added that Danone's commitment is to bring health through nutrition and hydration to as many people as possible.
The investment will create 12 new positions to join 181 employees at a 52,000 square-meter facility.


Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Google Secures Pentagon AI Deal for Classified Projects
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 



